Virtual Library

Start Your Search

S.S. Rasmussen



Author of

  • +

    P2.07 - Poster Session/ Small Cell Lung Cancer (ID 222)

    • Event: WCLC 2015
    • Type: Poster
    • Track: Small Cell Lung Cancer
    • Presentations: 1
    • +

      P2.07-015 - Pattern of Failure after Definitive Radiotherapy for Small Cell Lung Cancer (ID 2423)

      09:30 - 09:30  |  Author(s): S.S. Rasmussen

      • Abstract
      • Slides

      Background:
      The standard of care for limited disease SCLC is chemo-radiotherapy. The recommended radiotherapy schedule is 45 Gy/30 F bi-daily (BD-RT) for patients in good performance status according to various guidelines. However, a large proportion of these patients are not able to fulfill the bi-daily schedule due to frailty. For these patients 45 Gy/25 F, once-daily (OD-RT) has been the standard of care at our institution. The aim of this study was to investigate the pattern of failure and survival after chemo-radiotherapy with the 2 different radiotherapy schedules.

      Methods:
      Records of 106 patients with limited disease SCLC treated from 2007 to 2013 with definitive chemo-radiotherapy in our institution were reviewed. The chemotherapy regimen was a platinum doublet with etoposide. The radiotherapy schedule for 69 patients was treatment OD-RT (45 Gy/25 F), whereas 37 patients were treated BD-RT (45 Gy/30 F). Log rank tests were used to compare overall survival (OS) and local failure free survival (LFS) between the groups.

      Results:
      In the OD-RT 23 patients (33%) were either alive or dead without evidence of recurrence, and 15 patients (41%) in the BD-RT. In the OD-RT 21 patients (30%) had locoregional recurrence only, 12 patients (17%) had locoregional and distant relapse, and 13 patients (19%) had distant metastasis only. In the BD-RT 8 patients (22%) had locoregional recurrence only, 8 patients (22%) had locoregional and distant failure, and 6 patients (16%) had distant relapse only. Statistically significant (p<0,05) differences in patient characteristics between the two groups were observed: fraction of Performance Status 0-1 93% vs 67%, fraction treated with PCI 78% vs 54% and mean age of 62 vs 67 years for the groups BD-RT and OD-RT respectively. No differences were observed in S-sodium, LDH or gender. The mean follow-up was 24 months. Median overall survival was 18 months in OD-RT and 24 months in BD-RT, and 2 year OS was 45% vs 43% respectively (p=0.23). Median local-failure free survival was 13 months in OD-RT vs 33 months in BD-RT, and 2 year LFS was 57% vs 40% respectively (p=0.19) Local failure free survuval: Figure 1



      Conclusion:
      In this study the locoregional control and overall survival was not significantly better in the bi-daily regimen with 45 Gy/30 F compared to once-daily treatment with 45 Gy/25 F. This was unexpected, because the two groups differed significantly in PS, PCI and age in favour of the bi-daily regimen. But the size sample was small and follow-up time short.

      Only Active Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login or select "Add to Cart" and proceed to checkout.